A Trial of Dehydroepiandrosterone (DHEA) Treatment for in Vitro Fertilization (IVF)

Stopped early · Phase 2/Phase 3

Conditions studied: Infertility, Decreased Ovarian Reserve

In brief

Our long term goal is to elucidate the role of DHEA on follicular dynamics in the human ovary and to better understand the interaction of DHEA supplementation with other treatments for ovulation induction, especially among older reproductive age women. The specific hypothesis behind the proposed research is that DHEA is a regulator of follicular dynamics acting in the early pre-gonadotropin dependent stage of initial primordial follicle recruitment and growth.

Key facts

Study ID

NCT00419913

Run by

Center for Human Reproduction

People needed

8

Starts

2007-01-01

Expected to finish

2008-01-01

Last updated by the study team

2008-04-02

Who can join

Age: 40 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women over the age of 40 and less than 45 years old presenting for IVF treatment.
• Willingness to sign informed consent for study randomization.
• Willingness to participate in 2 months pre-IVF treatment.

You may not qualify if…

• Medical condition that would contraindicate pregnancy, ovulation induction or general anesthesia.
• Family history of significant genetic disease, or factor V Leiden thrombophilia.
• Inability to present for monitoring visits.
• Inability to follow medication instruction.

Where it is running

• Center for Human Reproduction — New York, New York, United States
• Institute fur Reproduktionsmedzin und Endokrinologie — Bregenz, Austria

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.